Latest News

FDA Warns Consumers about Potential for Dangerous Health Effects that can result from Certain Topical Pain Relief Products The U.S. Food and Drug Administration is…

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine Etrasimod (Velsipity) on (11 March 2024) to treat people over the age of…

Today, the U.S. Food and Drug Administration approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver…

EMA’s safety committee (PRAC) concluded that there was insufficient evidence to establish a causal association between the COVID-19 vaccines Comirnaty and Spikevax and cases of postmenopausal…

The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have launched new lists that show where scientists can find real-world data and…

MHRA approved the Rubidium (Rb82) Generator (RUBY-FILL) as a diagnostic tool for imaging of the heart to aid in the diagnosis of suspected or known…

Pseudoephedrine is licensed for the symptomatic relief of nasal and sinus congestion in colds, flu, and allergies. It has been used in the UK for…

The U.S. Food and Drug Administration recently approved Aurlumyn (iloprost) injection for the treatment of severe frostbite in adults. This approval aims to reduce the…

EMA’s safety committee (PRAC) is reminding healthcare professionals of the risk of serious and potentially fatal adverse reactions with Paxlovid when used in combination with…

In a groundbreaking stride towards revolutionizing the field of stem cell therapy, the Head of the Medicines and Healthcare products Regulatory Agency’s UK Stem Cell…

In a significant development, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended against renewing the marketing authorization for…

Today, the U.S. Food and Drug Administration announced the creation of a new Digital Health Advisory Committee to help the agency explore the complex, scientific…

In a recent update, the Medicines and Healthcare products Regulatory Agency (MHRA) has released important information regarding statins and their potential link to myasthenia gravis.…

The Pharmacovigilance Risk Assessment Committee (PRAC) convened from September 25th to 28th, 2023, to review critical safety data. Among the significant outcomes was the decision…

 The U.S. Food and Drug Administration (FDA) has taken a monumental step towards combating rare diseases. In a recent announcement, the agency disclosed the allocation…